A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma
Eli Lilly and Company
Eli Lilly and Company
Novartis
Valent Technologies, LLC
Pfizer
Lumos Pharma
Washington University School of Medicine
Stanford University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Duke University
National Cancer Institute (NCI)
City of Hope Medical Center
National Institutes of Health Clinical Center (CC)
NYU Langone Health